Tractional and exudative detachment

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Retinal detachment describes anatomical separation, while its mechanism determines what needs treatment. In tractional disease, tissue attached to the retina contracts and pulls it away from the supporting retinal pigment epithelium. In exudative disease, leakage or disturbed fluid handling allows subretinal fluid to accumulate without a primary retinal break. Neither mechanism can be safely excluded by the absence of flashes. The presentation may instead be gradual distortion, reduced acuity or a changing field defect, and a substantial lesion can be found during assessment of apparently nonspecific blur.

Proliferative diabetic retinopathy can produce abnormal vessels along the retinal surface and into the vitreous. Fibrous tissue associated with these vessels can contract, tethering the retina. The risk to vision depends on its location, progression and relationship to the macula, together with haemorrhage and other active diabetic pathology. A peripheral stable tractional area and a progressively threatened macula do not warrant identical plans. NICE recommends offering vitrectomy when proliferative diabetic retinopathy is accompanied by macula-involving or macula-threatening retinal detachment.

Exudative detachment is a pattern requiring an explanation. The examiner considers inflammation, abnormal vascular permeability, a choroidal or retinal mass and other posterior-segment disease. Imaging should identify where fluid lies and whether there is a visible break, traction or underlying lesion. A diagnosis of serous fluid is not the endpoint of investigation. Treatment can be medical, oncological or procedural depending on the cause, and a generic retinal-break laser approach will not address every mechanism. Similarly, starting corticosteroids before assessing an infectious or neoplastic alternative can create diagnostic and treatment harm.

Key points

Tractional detachment occurs when contracting tissue pulls the retina away from its underlying support.
Proliferative diabetic retinopathy is an important setting because abnormal vessels can be accompanied by fibrovascular membranes.
Exudative detachment results from fluid accumulating beneath the retina without a causative retinal break.
Inflammation, vascular leakage and ocular tumours are possible causes of an exudative pattern.
Traction and retinal tearing can coexist, creating a combined mechanism that changes the urgency and repair.
Treatment addresses the identified mechanism: relieve important traction, control the cause of leakage, and repair any associated break when indicated.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Proliferative retinal disease

Abnormal retinal vessels may develop associated fibrous tissue that contracts against the retina. Proliferative diabetic retinopathy is an important clinical setting for tractional detachment.

Leakage and inflammation

Posterior inflammatory disorders and abnormal vascular permeability can cause subretinal fluid without a retinal break. The pattern of associated ocular findings directs the investigation.

Mass-related or traumatic disease

Ocular tumours or injury can disturb the normal posterior-segment fluid balance and produce exudative separation. A mass or relevant trauma history requires specific specialist evaluation.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Mechanical membrane contraction
Fibrovascular tissue attached to the retina contracts and pulls it away from underlying support. The location and progression of this tethering determine whether central retinal function is threatened.
2
Fluid accumulation
Subretinal fluid increases when leakage or altered fluid handling exceeds clearance. Retinal separation can therefore occur without a full-thickness break, defining the exudative mechanism.
3
Combined structural injury
Persistent traction can create a break, allowing liquefied vitreous to enter the subretinal space. A combined detachment requires assessment of both membrane forces and the break-related component.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Tethering in proliferative retinopathy

Fibrovascular tissue associated with abnormal vessels may distort or elevate the retina in a person with diabetic eye disease. Assess the macular relationship and whether haemorrhage limits the examination.

Fluid without a demonstrated break

Subretinal fluid with no identified causative tear raises an exudative possibility, but an adequate peripheral examination is still needed before declaring a break absent.

Central functional change

Metamorphopsia, impaired reading, reduced acuity or a central dark area suggests macular involvement. Symptoms should be mapped to retinal findings rather than attributed automatically to refractive change.

Clues to the underlying cause

Inflammation, an ocular mass, previous injury, systemic inflammatory symptoms and the history of diabetes guide targeted investigation. The same apparent retinal separation can therefore lead to different treatment teams.

Red flags requiring action

New field loss or declining central vision with suspected retinal separation needs emergency eye assessment, regardless of whether a break is visible.
Proliferative diabetic retinopathy with a detachment involving or threatening the macula requires a vitreoretinal surgical decision.
Subretinal fluid associated with a mass, ocular inflammation or unexplained systemic symptoms needs cause-directed specialist investigation; empirical steroid treatment may obscure important alternatives.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Visual function and dilated retinal examinationFirst step
Why
Map the detached area and identify associated traction, breaks or lesions.
Interpretation and limitations
Document acuity, field symptoms, macular relationship and peripheral findings. A poor view needs further assessment rather than an assumed non-rhegmatogenous diagnosis.
02
Macular and lesion-directed OCT
Why
Determine the location of fluid and the effect of traction on retinal layers.
Interpretation and limitations
OCT can distinguish intraretinal oedema, subretinal fluid and interface distortion within the scanned region. It does not by itself exclude a peripheral tear or identify every cause of leakage.
03
Selected retinal angiography or wider imaging
Why
Assess vascular activity, leakage and the distribution of posterior disease.
Interpretation and limitations
The retinal team selects imaging according to the suspected pathology and image quality. Diabetic assessment may use ultrawide-field imaging alongside clinical examination rather than as a replacement.
04
Ultrasound and targeted systemic investigations
Why
Clarify obscured anatomy, a possible mass or a clinically suspected systemic cause.
Interpretation and limitations
Choose tests to answer specific questions raised by examination. An undirected blood panel cannot substitute for imaging an ocular lesion, and pressure-based scanning is inappropriate if an open globe is suspected.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Rhegmatogenous detachment

A full-thickness retinal break permits fluid entry beneath the retina. A careful peripheral assessment is needed before attributing separation exclusively to traction or leakage.

Macular oedema

Fluid within central retinal layers can reduce vision without a broad retinal detachment. Imaging helps distinguish oedema from subretinal fluid and mechanical elevation, which may coexist.

Retinoschisis

Splitting within retinal layers differs anatomically from separation of the neurosensory retina from its underlying support. Specialist examination and imaging clarify the lesion and its implications.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01New retinal symptomsEstablish anatomy and immediate visual riskFirst stepVisual loss, distortion or a field change raises concern for retinal separation.

1Arrange same-day ophthalmic assessment for a new suspected detachment and record the onset and central visual impact.
2Identify diabetes, previous proliferative disease, recent treatment, trauma and inflammatory symptoms in the handover.
3Ensure the retinal examination considers a break as well as traction or leakage, particularly when the course is unexpectedly rapid.

02Diabetic tractional diseaseLink macular threat to a surgical planProliferative diabetic retinopathy is associated with a tractional retinal detachment.

1NICE recommends offering vitrectomy when diabetic detachment involves or threatens the macula; arrange prompt vitreoretinal assessment.
2If the detachment neither involves nor threatens the macula, consider vitrectomy when complete panretinal photocoagulation has been followed by persistent active proliferative disease or recurring vitreous haemorrhage related to active proliferation or vitreomacular traction.
3Coordinate treatment of active proliferative disease and other retinal pathology, with close vitreoretinal collaboration when anti-VEGF treatment is used in an eye with traction.

03Exudative patternTreat the cause of subretinal fluidSpecialist assessment identifies fluid-related separation without a causative break.

1Investigate the suspected inflammatory, vascular or mass-related cause using the clinical pattern and appropriate imaging.
2Agree the relevant medical-retina, uveitis or ocular-oncology pathway instead of treating every fluid collection as a tear needing laser.
3Monitor retinal anatomy and visual function as the underlying disease is treated, reconsidering the diagnosis if the expected response does not occur.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Macular functional loss

Progressive traction or subretinal fluid can involve the macula and impair central vision. The extent and duration of structural disturbance influence recovery after treatment.

Haemorrhage and combined detachment

Fragile proliferative vessels can bleed, while traction may create a retinal break. These events can obscure examination or accelerate a previously more gradual clinical course.

Unrecognised underlying disease

Treating fluid as an isolated finding can delay diagnosis of inflammation, vascular pathology or a tumour. Persistent or unexpected findings require reassessment of the proposed cause.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Assess each eye's active pathology separately, including proliferative disease, macular oedema, traction and haemorrhage; improvement in one component does not establish control of the others.
Serial acuity and OCT or other selected imaging can document progression towards the macula or response of subretinal fluid to cause-directed therapy.
When anti-VEGF treatment is given in an eye with vitreoretinal traction or tractional detachment, use close monitoring in collaboration with a vitreoretinal specialist.
Check that follow-up remains with the appropriate hospital team rather than reverting to screening while active complex retinal disease is still being treated.
A new curtain, sudden loss of vision or abrupt increase in floaters requires earlier review because haemorrhage or a new break can alter the original mechanism.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Mechanisms may be combined

A membrane can exert sufficient force to create a retinal break, adding fluid entry to the original traction. An apparently established diabetic explanation should not prevent reconsideration when symptoms accelerate.

Macular oedema is not the same lesion

Diabetic macular oedema involves fluid within or around central retinal structures, while tractional detachment lifts the retina mechanically. OCT helps clarify which processes coexist and which intervention is intended to address each.

Retinal screening has a different purpose

A routine screening appointment identifies and grades diabetic retinopathy. It is not the appropriate waiting point for a patient with new visual symptoms and possible detachment who needs clinical assessment.

Control systemic contributors in parallel

Glycaemic and blood-pressure care supports long-term retinal health, but does not immediately release a threatening membrane or establish the cause of exudative fluid. Coordinate systemic care alongside the ocular treatment.

11Common pitfallsFrequent interpretation and management errors.

01
Excluding retinal detachment because there are no flashes or because no tear was visible on a limited examination.
02
Assuming every diabetic visual complaint is macular oedema and overlooking traction approaching the macula.
03
Starting an empirical ocular or systemic steroid for unexplained subretinal fluid before the cause has been assessed.
04
Applying the monitoring interval for one retinal disorder to a combined tractional, haemorrhagic or break-related process.